NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma

International Journal of Cancer

Volumn 137, Issue 8, 2015, Pages 1879-1889

  Gaykalova, Daria A ^a   Manola, Judith B ^b   Ozawa, Hiroyuki ^a   Zizkova, Veronika ^a,c   Morton, Kathryn ^a   Bishop, Justin A ^a   Sharma, Rajni ^a   Zhang, Chi ^a,d   Michailidi, Christina ^a   Considine, Michael ^a   Tan, Marietta ^a   Fertig, Elana J ^a   Hennessey, Patrick T ^a,g   Ahn, Julie ^a   Koch, Wayne M ^a   Westra, William H ^a   Khan, Zubair ^a   Chung, Christine H ^a   Ochs, Michael F ^a,e   Califano, Joseph A ^a,f  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c PALACKÝ UNIVERSITY   (Czech Republic)

^d UNIVERSITY OF VIRGINIA   (United States)

^e The College of New Jersey   (United States)

^f GREATER BALTIMORE MEDICAL CENTER   (United States)

^g and Throat ^*  (United States)

Author keywords

HNSCC; HPV; NF B; STAT3; transcription factor

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN DELTA; CYCLIN D1; DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON REGULATORY FACTOR 1; JAGGED1; JANUS KINASE 3; PROTEIN P53; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RELA; TUMOR MARKER; STAT3 PROTEIN, HUMAN;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA METHYLATION; DRUG TARGETING; GENE DOSAGE; GENE EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KNOWLEDGE BASE; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; WART VIRUS; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; METABOLISM; PAPILLOMAVIRUS INFECTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRUS INFECTIONS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84938951703     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29558     Document Type: Article

References (51)

1. Siegel R, Ma J, Zou Z, et al., Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
2. Psyrri A, Boutati E, Karageorgopoulou S,. Human papillomavirus in head and neck cancers: biology, prognosis, hope of treatment, and vaccines. Anticancer Drugs 2011; 22: 586-90.
3. Chaturvedi AK, Engels EA, Pfeiffer RM, et al., Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29: 4294-301.
4. Smith IM, Mydlarz WK, Mithani SK, et al., DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage. Int J Cancer 2007; 121: 1724-8.
5. Bonner JA, Harari PM, Giralt J, et al., Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 2010; 11: 21-8.
6. Lui VW, Hedberg ML, Li H, et al., Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discov 2013; 3: 761-9.
7. Agrawal N, Frederick MJ, Pickering CR, et al., Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in notch1. Science 2011; 333: 1154-7.
8. Sun W, Gaykalova DA, Ochs MF, et al., Activation of the NOTCH pathway in head and neck cancer. Cancer Res 2014; 74: 1091-104.
9. Fertig EJ, Markovic A, Danilova LV, et al., Preferential activation of the hedgehog pathway by epigenetic modulations in HPV negative HNSCC identified with meta-pathway analysis. PloS One 2013; 8: e78127
10. Chung CH, Parker JS, Karaca G, et al., Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 2004; 5: 489-500.
11. Tootle TL, Rebay I,. Post-translational modifications influence transcription factor activity: a view from the ETS superfamily. Bioessays 2005; 27: 285-98.
12. Allen C, Saigal K, Nottingham L, et al., Bortezomib-induced apoptosis with limited clinical response is accompanied by inhibition of canonical but not alternative nuclear factor-{kappa}B subunits in head and neck cancer. Clin Cancer Res 2008; 14: 4175-85.
13. Gill JS, Zhu X, Moore MJ, et al., Effects of NFkappaB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line. Biomaterials 2002; 23: 2773-81.
14. Sen M, Paul K, Freilino ML, et al., Systemic administration of a cyclic signal transducer and activator of transcription 3 (stat3) decoy oligonucleotide inhibits tumor growth without inducing toxicological effects. Mol Med 2014; 20: 46-56.
15. Rathi KS, Gaykalova DA, Hennessey P, et al., Correcting transcription factor gene sets for copy number and promoter methylation variations. Drug Dev Res, 2014; 75 (6): 343-7.
16. Carvalho AL, Henrique R, Jeronimo C, et al., Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance. Clin Cancer Res 2011; 17: 4782-9.
17. Singhi AD, Califano J, Westra WH,. High-risk human papillomavirus in nasopharyngeal carcinoma. Head Neck 2012; 34: 213-8.
18. Matys V, Fricke E, Geffers R, et al., TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res 2003; 31: 374-8.
19. Scharpf RB, Irizarry RA, Ritchie ME, et al., Using the R package crlmm for genotyping and copy number estimation. J Stat Softw 2011; 40: 1-32.
20. Nottingham LK, Yan CH, Yang X, et al., Aberrant IKKalpha and IKKbeta cooperatively activate NF-kappaB and induce EGFR/ap1 signaling to promote survival and migration of head and neck cancer. Oncogene 2014; 33: 1135-47.
21. Rampias T, Sasaki C, Weinberger P, et al., e6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. J Natl Cancer Inst 2009; 101: 412-23.
22. Haraf DJ, Nodzenski E, Brachman D, et al., Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res 1996; 2: 755-62.
23. Poeta ML, Manola J, Goldwasser MA, et al., tp53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med 2007; 357: 2552-61.
24. Geman D, d'Avignon C, Naiman DQ, et al., Classifying gene expression profiles from pairwise mRNA comparisons. Stat Appl Genet Mol Biol 2004; 3: Article19
25. Leek JT,. The tspair package for finding top scoring pair classifiers in R. Bioinformatics 2009; 25: 1203-4.
26. Hatakeyama H, Cheng H, Wirth P, et al., Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma. PloS One 2010; 5: e12702
27. Lee TL, Yang XP, Yan B, et al., A novel nuclear factor-kappaB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with tp53 status. Clin Cancer Res 2007; 13: 5680-91.
28. Wang Q, Huber N, Noel G, et al., NF-kappaBeta inhibition is ineffective in blocking cytokine-induced IL-8 production but p38 and stat1 inhibitors are effective. Inflamm Res 2012; 61: 977-85.
29. Sun J, Blaskovich MA, Jove R, et al., Cucurbitacin Q: a selective stat3 activation inhibitor with potent antitumor activity. Oncogene 2005; 24: 3236-45.
30. Haftchenary S, Luchman HA, Jouk AO, et al., Potent targeting of the stat3 protein in brain cancer stem cells: a promising route for treating glioblastoma. ACS Med Chem Lett 2013; 4: 1102-7.
31. Weinberger PM, Yu Z, Haffty BG, et al., Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24: 736-47.
32. Yan B, Chen G, Saigal K, et al., Systems biology-defined NF-kappaB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 status. Genome Biol 2008; 9: R53
33. Yan B, Yang X, Lee TL, et al., Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-kappaB and other signal transcription factors in head and neck squamous cell carcinoma. Genome Biol 2007; 8: R78
34. Squarize CH, Castilho RM, Sriuranpong V, et al., Molecular cross-talk between the NFkappaB and stat3 signaling pathways in head and neck squamous cell carcinoma. Neoplasia 2006; 8: 733-46.
35. Li Q, Verma IM,. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002; 2: 725-34.
36. Dauer DJ, Ferraro B, Song L, et al., stat3 regulates genes common to both wound healing and cancer. Oncogene 2005; 24: 3397-408.
37. Cho HJ, Kang JH, Kwak JY, et al., Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the ras/raf/MEK/ERK- and Ap1-dependent mechanisms. Carcinogenesis 2007; 28: 1104-10.
38. Ondrey FG, Dong G, Sunwoo J, et al., Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-il6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines. Mol Carcinog 1999; 26: 119-29.
39. Song JI, Grandis JR,. STAT signaling in head and neck cancer. Oncogene 2000; 19: 2489-95.
40. Vandermark ER, Deluca KA, Gardner CR, et al., Human papillomavirus type 16 e6 and E 7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalization. Virology 2012; 425: 53-60.
41. Sato O, Kuriki C, Fukui Y, et al., Dual promoter structure of mouse and human fatty acid translocase/cd36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor alpha and gamma ligands. J Biol Chem 2002; 277: 15703-11.
42. Bancroft CC, Chen Z, Yeh J, et al., Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int J Cancer 2002; 99: 538-48.
43. Lee SJ, Qin H, Benveniste EN,. Simvastatin inhibits IFN-gamma-induced cd40 gene expression by suppressing STAT-1alpha. J Leukoc Biol 2007; 82: 436-47.
44. McArdle MA, Finucane OM, Connaughton RM, et al., Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front Endocrinol (Lausanne) 2013; 4: 52
45. Lee TL, Yeh J, Friedman J, et al., A signal network involving coactivated NF-kappaB and stat3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas. Int J Cancer 2008; 122: 1987-98.
46. Gaykalova DA, Mambo E, Choudhary A, et al., Novel insight into mutational landscape of head and neck squamous cell carcinoma. PloS One 2014; 9: e93102
47. Freed-Pastor WA, Prives C,. Mutant p53: one name, many proteins. Genes Dev 2012; 26: 1268-86.
48. Redmond AM, Carroll JS,. Defining and targeting transcription factors in cancer. Genome Biol 2009; 10: 311
49. Yeh JE, Toniolo PA, Frank DA,. Targeting transcription factors: promising new strategies for cancer therapy. Curr Opin Oncol 2013; 25: 652-8.
50. Turkson J, Kim JS, Zhang S, et al., Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity. Mol Cancer Ther 2004; 3: 261-9.
51. Sen M, Thomas SM, Kim S, et al., First-in-human trial of a stat3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy. Cancer Discov 2012; 2: 694-705.